PHIOGEN

Serial Number 97979443
Registration 7725055
700

Registration Progress

Application Filed
Aug 31, 2022
Under Examination
Sep 19, 2023
Approved for Publication
Jul 25, 2023
Published for Opposition
Jul 25, 2023
Registered
Mar 11, 2025

Trademark Image

PHIOGEN

Basic Information

Serial Number
97979443
Registration Number
7725055
Filing Date
August 31, 2022
Registration Date
March 11, 2025
Published for Opposition
July 25, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 11, 2025
Registration
Registered
Classes
042

Rights Holder

Baylor College of Medicine

99
Address
Mail Slot BCM 105, One Baylor Plaza
Houston, TX 77030

Ownership History

Baylor College of Medicine

Original Applicant
99
Houston, TX

Baylor College of Medicine

Owner at Publication
99
Houston, TX

Baylor College of Medicine

Original Registrant
99
Houston, TX

Legal Representation

Attorney
Alicia Morris Groos

USPTO Deadlines

Next Deadline
2052 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-11)
Due Date
March 11, 2031
Grace Period Ends
September 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Mar 11, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 11, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 19, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 19, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 19, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 19, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 19, 2025 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Nov 19, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 4, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Sep 4, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 4, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Sep 4, 2024 IUAF S USE AMENDMENT FILED Loading...
Mar 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 19, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 19, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 19, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals
First Use Anywhere: May 31, 2023
First Use in Commerce: May 31, 2023

Classification

International Classes
042